Business Description
HighTide Therapeutics Inc
ISIN : KYG4568L1023
Total Employee Number:
51Compare
Compare
Traded in other countries / regions
02511.Hong KongHTTIF.USA IPO Date
2024-04-05Description
HighTide Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of first-in-class multifunctional, multi-targeted therapies for cardiovascular-kidney-metabolic (CKM) diseases and related metabolic disorders. The company is developing a pipeline of proprietary drug candidates targeting indications including type 2 diabetes mellitus, chronic kidney disease, obesity, metabolic dysfunction-associated steatohepatitis (MASH), and primary sclerosing cholangitis (PSC). Its core product candidate, HTD1801 (berberine ursodeoxycholate), is an orally delivered first-in-class anti-inflammatory metabolic modulator designed to target dual pathways involving AMPK activation and NLRP3 inflammasome inhibition.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.96 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.41 | |||||
Debt-to-EBITDA | -0.57 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 14.6 | |||||
3-Year EPS without NRI Growth Rate | 14.6 | |||||
3-Year FCF Growth Rate | 20.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
9-Day RSI | 0.09 | |||||
14-Day RSI | 1.17 | |||||
6-1 Month Momentum % | 4.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.41 | |||||
Quick Ratio | 5.41 | |||||
Cash Ratio | 5.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.9 | |||||
Shareholder Yield % | -12.54 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -67.29 | |||||
ROA % | -42.87 | |||||
ROIC % | -231.37 | |||||
3-Year ROIIC % | -0.43 | |||||
ROC (Joel Greenblatt) % | -1120.74 | |||||
ROCE % | -54.15 | |||||
Moat Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 4.44 | |||||
Price-to-Tangible-Book | 4.37 | |||||
EV-to-EBIT | -4.24 | |||||
EV-to-EBITDA | -4.35 | |||||
EV-to-FCF | -5.84 | |||||
| Price-to-Net-Current-Asset-Value | 5 | |||||
| Price-to-Net-Cash | 5 | |||||
Earnings Yield (Greenblatt) % | -23.58 | |||||
FCF Yield % | -12.16 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HTTIF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HighTide Therapeutics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.072 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 1.17 | ||
| 14-Day ATR ($) | 0.002625 | ||
| 20-Day SMA ($) | 0.385275 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.3358 - 0.4883 | ||
| Shares Outstanding (Mil) | 508.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HighTide Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HighTide Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
HighTide Therapeutics Inc Frequently Asked Questions
What is HighTide Therapeutics Inc(HTTIF)'s stock price today?
The current price of HTTIF is $0.35. The 52 week high of HTTIF is $0.49 and 52 week low is $0.34.
When is next earnings date of HighTide Therapeutics Inc(HTTIF)?
The next earnings date of HighTide Therapeutics Inc(HTTIF) is .
Does HighTide Therapeutics Inc(HTTIF) pay dividends? If so, how much?
HighTide Therapeutics Inc(HTTIF) does not pay dividend.
Guru Commentaries on OTCPK:HTTIF
No articles.
Press Release
Articles on HighTide Therapeutics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers